OMEICOS Therapeutics

0 followers

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Headquarters

Berlin, Germany

Employees

11-50

Links


Org chart

Co-Founder, CEO & CSO
Collapse
Chief Business Officer
Vice President Operations & IP
Consultant, Medicinal Chemistry & CMC
Head of Finance & Controlling
R&D Scientist

Board & advisors

Supervisory Board Chairman
Board Member
Board Member
Board Member
Board Member